Awards and Prizes

This award honors an individual who has made significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work.

For a scientist residing in any country in the world for his or her seminal contributions to the field of cancer prevention. Such investigations must have been conducted in basic, translational, clinical, epidemiological, or behavioral science in cancer prevention research. Further, these studies must have had not only a major impact on the field, but must also have stimulated new directions in this important area.

This award recognizes a young investigator (not more than 40 years of age) on the basis of meritorious achievement in cancer research.

This award is presented for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, the prevention of cancer, or the treatment of patients with cancer.

For outstanding preclinical research in the fields of medicinal chemistry, biochemistry, or tumor biology as related to drug discovery that has implications for the improved care of cancer patients. (Final award was presented in 2006.)

This award recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.

This award recognizes outstanding recent accomplishments in basic cancer research.

This award recognizes outstanding achievements in clinical cancer research.

This award recognizes an individual whose leadership and extraordinary achievements have made a major impact in cancer research.

This award recognizes a scientist whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

This award honors the recipient and provides incentive to investigators relatively early in their careers (not more than 50 years of age) who are engaged in the practice of medicine, for research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer.

The AACR Team Science Award has been established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications.

This award recognizes a worthy cancer researcher who has conducted highly meritorious laboratory, translational, or clinical cancer anywhere in the world at a relatively early state in his or her career.

European School of Oncology established the Best Cancer Reporter Award in 2006 to promote intelligent and critical coverage of cancer and acknowledge the many examples of excellent reporting on the topic by journalists across Europe.

This Prize will recognize the impact of research carried out by an early career scientist, that is, one who has been awarded a PhD within the last 10 years. It is expected that the Recipient will have produced international quality research, and be able to demonstrate the ambition and aspirations consistent with the potential to achieve world-leading status.

This Prize will honor an individual at any career stage who has produced international quality research in the field of prevention or early detection of cancer.

This Prize will honor an individual who has made significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work. These contributions, whether they have been in research, leadership, or mentorship, will have had a lasting impact on the cancer field and will have demonstrated a lifetime commitment to progress against cancer.

This Prize will recognize important translational research achievements in the continuing effort to prevent and cure cancer and to recognize and reward cancer scientists for these extraordinary accomplishments. The Prize will be made to an outstanding Team that has made seminal cancer research discoveries at the cutting edge of scientific novelty and significance. Such discoveries must have accelerated progress against cancer and must have implications for future discoveries and contributions to cancer research. Team members do not necessarily need to be at the same Institution or even in the same country, although at least one major member of the team must have carried out their work in the UK.

Last awarded in 2009, this prize promoted and rewarded extraordinary achievements in translational cancer research.

Last awarded in 2009, this prize promoted and rewarded seminal contributions to the understanding of cancer through basic cancer research.

The Paul Marks Prize for Cancer Research recognizes a new generation of leaders in cancer research, who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research. The prize is intended to encourage young investigators who have a unique opportunity to help shape the future of cancer research.

This award is presented to a scientist of international renown who has made a major scientific discovery in basic or translational cancer research.